Drug Administration Law

Drug Administration Law of the People’s Republic of China
中华人民共和国药品管理法

[Current Text: Chinese, English]

(adopted Sept. 20, 1984, effective July 1, 1985; revised Feb. 28, 2001, effective Dec. 1, 2001; amended and effective Dec. 28, 2013; amended and effective Apr. 24, 2015; revised Aug. 26, 2019, effective Dec. 1, 2019)

• Status: Revision passed
• Legislative Body (Vote): NPCSC (164–3–0)
• Principal Drafter: State Administration for Market Regulation
• Submitter: State Council
• Legislative Plans
  • Five-year: 11^th NPCSC Category I; 12^th NPCSC Category II; 13^th NPCSC Category I
  • Annual: N/A
• Legislative History & Text
  • NPCSC deliberation – 3^rd (final) round: August 2019 (Current Text ⇧)
  • NPCSC deliberation – 2^nd round: April 2019 (Chinese only)
  • NPCSC deliberation – 1^st round: October 2018 (Chinese only)
• Legislative Records: 
  • Explanation (Oct. 22, 2018)
  • Report on Status of Revision (Apr. 20, 2019)
  • Report on Results of Deliberation (Aug. 22, 2019)
  • Report on Suggestions for Revision (Aug. 25, 2019)
  • Presidential Order (Aug. 26, 2019)
• Press Conference: NPCSC General Office (Aug. 26, 2019)

NPC Observer Coverage

• NPCSC Revamps Drug Law, Overhauls Rural Land Expropriation Rules & Passes Resource Tax Law (Aug. 27, 2019)
• NPCSC Solicits Public Comments on Draft Securities Law Revision, Civil Code Parts on Property and Personality Rights & Drug and Vaccine Laws (Apr. 26, 2019)
• NPCSC Solicits Public Comments on Draft Revision to Civil Servants Law and Three Other Bills (Nov. 1, 2018)